All tenders
75A50123C00050
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
Office of Assistant Secretary for Preparedness and Response · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75A50123C00050
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS.
- Source
- USASpending (Federal)
- Source ID
- usa-75A50123C00050
Details
- Location
- United States
Description
VENATORX PHARMACEUTICALS: NEW ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA INCLUDING PUBLIC HEALTH PATHOGENS. Awarded to: BASILEA PHARMACEUTICA INTERNATIONAL LTD, ALLSCHWIL Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2023/09/15 12:00:00 AM UTC
- Closing date
- 2027/12/31 12:00:00 AM UTC
Estimated value
$45.2M USD
Classification
Normalized category
Healthcare & Medical